The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ANAPTYSBIO INC | COM | 032724106 | 6,424,885 | 357,733 | SH | SOLE | 357,733 | 0 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 6,284,800 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | |||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 4,246,241 | 665,555 | SH | SOLE | 665,555 | 0 | 0 | |||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 8,538,630 | 310,270 | SH | SOLE | 310,270 | 0 | 0 | |||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 1,068,936 | 1,134,511 | SH | SOLE | 1,134,511 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 7,706,790 | 790,440 | SH | SOLE | 790,440 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 13,748,386 | 462,286 | SH | SOLE | 462,286 | 0 | 0 | |||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | 20,125,849 | 1,472,264 | SH | SOLE | 1,472,264 | 0 | 0 | |||
| DISC MEDICINE INC | COM | 254604101 | 20,598,005 | 438,442 | SH | SOLE | 438,442 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 70,498,919 | 5,160,975 | SH | SOLE | 5,160,975 | 0 | 0 | |||
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | 69,652,388 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | |||
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 4,064,260 | 404,404 | SH | SOLE | 404,404 | 0 | 0 | |||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 5,307,025 | 4,535,919 | SH | SOLE | 4,535,919 | 0 | 0 | |||
| IMPEL PHARMACEUTICALS INC | COM | 45258K109 | 1,240,460 | 2,884,791 | SH | SOLE | 2,884,791 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,657,350 | 1,305,000 | SH | SOLE | 1,305,000 | 0 | 0 | |||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,385,300 | 192,500 | SH | SOLE | 192,500 | 0 | 0 | |||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 17,852,970 | 313,210 | SH | SOLE | 313,210 | 0 | 0 | |||
| PHARVARIS N V | COM | N69605108 | 12,263,212 | 587,600 | SH | SOLE | 587,600 | 0 | 0 | |||
| RALLYBIO CORP | COM | 75120L100 | 12,235,540 | 3,630,724 | SH | SOLE | 3,630,724 | 0 | 0 | |||
| SCPHARMACEUTICALS INC | COM | 810648105 | 8,548,607 | 1,200,647 | SH | SOLE | 1,200,647 | 0 | 0 | |||
| SPRUCE BIOSCIENCES INC | COM | 85209E109 | 5,342,640 | 2,364,000 | SH | SOLE | 2,364,000 | 0 | 0 | |||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 5,665,667 | 411,450 | SH | SOLE | 411,450 | 0 | 0 | |||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 6,475,950 | 585,000 | SH | SOLE | 585,000 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 6,289,400 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM | 929033108 | 13,486,853 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 | |||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 9,829,400 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | |||